12891206

Source:http://linkedlifedata.com/resource/pubmed/id/12891206

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0036043, umls-concept:C0288672, umls-concept:C0403447, umls-concept:C0522523, umls-concept:C1522318, umls-concept:C1948041
pubmed:issue	2
pubmed:dateCreated	2003-7-31
pubmed:abstractText	Patients with chronic renal insufficiency (CRI) have worse outcomes during and after percutaneous coronary interventions (PCI). Abciximab reduces complications, but may cause excessive bleeding in patients with CRI. Therefore, we sought to determine the safety of abciximab in patients with CRI.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12891206-12891186
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370465
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/abciximab
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1097-6744
pubmed:author	pubmed-author:BellMalcolm RMR, pubmed-author:BergerPeter BPB, pubmed-author:BestPatricia J MPJ, pubmed-author:GershBernard JBJ, pubmed-author:HerzogCharles ACA, pubmed-author:HolmesDavid RDRJr, pubmed-author:LennonRyanR, pubmed-author:RihalCharanjit SCS, pubmed-author:TingHenry HHH
pubmed:issnType	Electronic
pubmed:volume	146
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	345-50
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12891206-Aged, pubmed-meshheading:12891206-Analysis of Variance, pubmed-meshheading:12891206-Angioplasty, Balloon, Coronary, pubmed-meshheading:12891206-Antibodies, Monoclonal, pubmed-meshheading:12891206-Coronary Angiography, pubmed-meshheading:12891206-Coronary Disease, pubmed-meshheading:12891206-Creatinine, pubmed-meshheading:12891206-Female, pubmed-meshheading:12891206-Follow-Up Studies, pubmed-meshheading:12891206-Hemorrhage, pubmed-meshheading:12891206-Humans, pubmed-meshheading:12891206-Immunoglobulin Fab Fragments, pubmed-meshheading:12891206-Kidney Failure, Chronic, pubmed-meshheading:12891206-Logistic Models, pubmed-meshheading:12891206-Male, pubmed-meshheading:12891206-Middle Aged, pubmed-meshheading:12891206-Platelet Aggregation Inhibitors, pubmed-meshheading:12891206-Risk
pubmed:year	2003
pubmed:articleTitle	Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions.
pubmed:affiliation	Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.
pubmed:publicationType	Journal Article